Found 12 matching trials
Serious Gaming for Chemotherapy-induced Nausea and Vomiting NA The purpose of this study is to examine the effectiveness of a technology-b...
Show More Location
Miller School of Medicine Sylvester Comp. Cancer Center
Learn More & Join Trial
Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED) PHASE3 This study will demonstrate and confirm the efficacy and safety of MK0869 f...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097) PHASE3 This study is being conducted to demonstrate that aprepitant (MK-0869) prev...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045) PHASE4 The purpose of this study is to evaluate the safety and tolerability of a 3...
Show More Location
Phoenix Childrens Hospital ( Site 1101)
Learn More & Join Trial
Evaluating the Feasibility and Acceptability of Inhalation Aromatherapy for Patients Undergoing Autologous Haematopoietic Stem Cell Transplant (HSCT) NA The goal of this clinical trial is to evaluate whether aromatherapy inhaler...
Show More Status
Enrolling By Invitation
Location
Singapore General Hospital
Learn More & Join Trial
Prevention of Chemotherapy Induced Nausea and Vomiting in Breast Cancer Patients. PHASE4 For breast cancer patients receiving chemotherapy regimens, the use of a va...
Show More Location
The Ottawa Hospital Cancer Centre
Learn More & Join Trial
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV) PHASE2 The purpose of this study is to evaluate the use of aromatherapy to reduce ...
Show More Location
University of Miami
Learn More & Join Trial
Aromatherapy Combined With Standard Antiemetic Therapy vs Standard Therapy Alone for Prevention of CINV in Breast Cancer Patients Receiving Highly Emetogenic Chemotherapy PHASE3 This phase III, multicenter, randomized, open-label trial evaluates whether...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer PHASE2 The purpose of this study is to check how well LY35327021 works and how saf...
Show More Location
Marin Cancer Care
Learn More & Join Trial
Netupitant and Palonosetron Hydrochloride in Preventing Chemotherapy Induced Nausea and Vomiting in Patients With Cancer Undergoing BEAM Conditioning Regimen Before Stem Cell Transplant PHASE2 This phase II trial studies how well netupitant and palonosetron hydrochlor...
Show More Location
OHSU Knight Cancer Institute
Learn More & Join Trial